Breaking News, Collaborations & Alliances

Dalton Pharma Forms Manufacturing Agreement with Andes Biotechnologies

Will supply large molecule sterile dose manufacturing services for their Phase I/II clinical trials

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Dalton Pharma Services has signed a new service contract with Andes Biotechnologies to supply large molecule sterile dose manufacturing services for their Phase I/II clinical trials. The agreement includes the cGMP sterile manufacturing of clinical materials, which Dalton will perform in its recently upgraded cGMP sterile manufacturing facility, located in Toronto, Canada. Dalton will also be performing the transfer of analytical methods and analytical release testing of the product in its Healt...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters